MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1

被引：0
|
作者：
Jing Liu
Kai-Hua Lu
Zhi-Li Liu
Ming Sun
Wei De
Zhao-Xia Wang
机构：
[1] The Second Affiliated Hospital of Nanjing Medical University,Department of Oncology
[2] Nanjing University,Immunology and Reproductive Biology Lab of Medical School and State Key Laboratory of Pharmaceutical Biotechnology
[3] The First Affiliated Hospital of Nanjing Medical University,Department of Oncology
[4] Nanjing Medical University,Department of Biochemistry and Molecular Biology
来源：
BMC Cancer | / 12卷
关键词：
A549 Cell; NSCLC Patient; NSCLC Cell; NSCLC Tissue; Nontumor Tissue;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer
    Zeng, Yu
    Li, Nanhong
    Liu, Wang
    Zeng, Mingqing
    Cheng, Junfen
    Huang, Jian
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (10) : 2447 - 2460
  • [22] microRNA-137 functions as a tumor suppressor in human non-small cell lung cancer by targeting SLC22A18
    Zhang, Bicheng
    Liu, Tao
    Wu, Tingting
    Wang, Zhigang
    Rao, Zhiguo
    Gao, Jianfei
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2015, 74 : 111 - 118
  • [23] MicroRNA-212 functions as a tumor-suppressor in human non-small cell lung cancer by targeting SOX4
    Tang, Tingting
    Huan, Liting
    Zhang, Shujuan
    Zhou, Hui
    Gu, Lei
    Chen, Xiaohui
    Zhang, Liang
    ONCOLOGY REPORTS, 2017, 38 (04) : 2243 - 2250
  • [24] MicroRNA-1976 functions as a tumor suppressor and serves as a prognostic indicator in non-small cell lung cancer by directly targeting PLCE1
    Chen, Gang
    Hu, Jing
    Huang, Zhao
    Yang, Lijing
    Chen, Min
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 473 (04) : 1144 - 1151
  • [25] Polo-like kinase 4 correlates with greater tumor size, lymph node metastasis and confers poor survival in non-small cell lung cancer
    Zhou, Qin
    Fan, Gongchun
    Dong, Yuanyuan
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (04)
  • [26] Can the P53 status predict the outcome of Polo-like kinase 1 inhibition in non-small cell lung cancer cell lines?
    Van den Bossche, J.
    Wouters, A.
    Deben, C.
    Deschoolmeester, V.
    Specenier, P.
    Pauwels, P.
    Peeters, M.
    Lardon, F.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 27 - 27
  • [27] Synaptic acetylcholinesterase targeted by microRNA-212 functions as a tumor suppressor in non-small cell lung cancer
    Lu, Lu
    Zhang, Xuejin
    Zhang, Bo
    Wu, Jun
    Zhang, Xuejun
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2013, 45 (11): : 2530 - 2540
  • [28] Epithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer
    Ferrarotto, Renata
    Goonatilake, Ruchitha
    Yoo, Suk Young
    Tong, Pan
    Giri, Uma
    Peng, Shaohua
    Minna, John
    Girard, Luc
    Wang, Yuehong
    Wang, Liguang
    Li, Lerong
    Diao, Lixia
    Peng, David H.
    Gibbons, Don L.
    Glisson, Bonnie S.
    Heymach, John V.
    Wang, Jing
    Byers, Lauren A.
    Johnson, Faye M.
    CLINICAL CANCER RESEARCH, 2016, 22 (07) : 1674 - 1686
  • [29] The effects of microRNA modulation of polo-like kinase 1 in breast cancer cell lines
    Zalles, N.
    Gasparini, P.
    Croce, C. M.
    CANCER RESEARCH, 2019, 79 (04)
  • [30] The role of polo-like kinase1 inhibition in Small Cell Lung Carcinomas
    Noro, Rintaro
    Omori, Miwako
    Fukuizum, Aya
    Yoshikawa, Akiko
    Sugano, Teppai
    Takano, Natsuki
    Hisagane, Kakeru
    Minegishi, Yuji
    Miyanaga, Akihiko
    Seike, Masahiro
    Kubota, Kaoru
    Gemma, Akihiko
    ANNALS OF ONCOLOGY, 2018, 29
12345